KALYANI MENON-SEN Campaign for Affordable Trastuzumab +91-9910306382 Swiss pharma major Roche has just announced that it is relinquishing the patent for its breast-cancer drug Trastuzumab (Herceptin) in India. The announcement comes in the face of mounting challenges – from both civil society and the Ministry of Health – to Roche’s monopoly on this life-saving drug. [...]
↧
Roche relinquishes Trastuzumab patent in India: Campaign urges fast track approval for bio-similars
↧